FULTRANSA

Serial Number 97271823
606

Registration Progress

Application Filed
Feb 17, 2022
Under Examination
Mar 7, 2023
Approved for Publication
Jan 10, 2023
Published for Opposition
Jan 10, 2023
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: FULTRANSA
Previous Owner: Johnson & Johnson
Classes: 005

Trademark Image

FULTRANSA

Basic Information

Serial Number
97271823
Filing Date
February 17, 2022
Published for Opposition
January 10, 2023
Abandonment Date
October 13, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 13, 2025
Classes
005

Rights Holder

Johnson & Johnson

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

Johnson & Johnson

Original Applicant
03
New Brunswick, NJ

Johnson & Johnson

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Danielle R. Weitzman

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description Documents
Oct 13, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 13, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 19, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 19, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 19, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 19, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 12, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 12, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 12, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 5, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 4, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 4, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 30, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 30, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 7, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 10, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 10, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 21, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 1, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 28, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 28, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 28, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 23, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 21, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification

International Classes
005